Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May 7;11(9):1915-8.
doi: 10.1021/ol9003492.

Diastereoselective pyrrolidine synthesis via copper promoted intramolecular aminooxygenation of alkenes: formal synthesis of (+)-monomorine

Affiliations

Diastereoselective pyrrolidine synthesis via copper promoted intramolecular aminooxygenation of alkenes: formal synthesis of (+)-monomorine

Monissa C Paderes et al. Org Lett. .

Abstract

The diastereoselectivity of the copper-promoted intramolecular aminooxygenation of various alkene substrates was investigated. Alpha-substituted 4-pentenyl sulfonamides favor the formation of 2,5-cis-pyrrolidines (dr >20:1) giving excellent yields which range from 76-97% while gamma-substituted substrates favor the 2,3-trans pyrrolidine adducts with moderate selectivity (ca. 3:1). A substrate whose N-substituent was directly tethered to the alpha-carbon exclusively yielded the 2,5-trans pyrrolidine. The synthetic utility of the method was demonstrated by a short and efficient formal synthesis of (+)-monomorine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Crystal structure of 31.
Scheme 1
Scheme 1
Copper(II) promoted diastereoselective formation of 2,5-cis-pyrrolidines and TEMPO trapping of radical intermediate.
Scheme 2
Scheme 2
Proposed mechanism for the formation of 2,5-cis-pyrrolidine.
Scheme 3
Scheme 3
Formal synthesis of (+)-monomorine.
Scheme 4
Scheme 4
Diastereoselective aminooxygenation of sulfonamide 29 forming the trans pyrrolidine 31.

Similar articles

Cited by

References

    1. Lewis JR. Nat. Prod. Rep. 2001;18:95–128. - PubMed
    2. O’Hagan D. Nat. Prod. Rep. 2000;17:435–446. - PubMed
    1. Nash RJ, Fellows LE, Dring JV, Fleet GWJ, Derome AE, Hamor TA, Scofield AM, Watkin DJ. Tetrahedron Lett. 1988;29:2487–2490.
    2. Scofield AM, Rossiter JT, Witham P, Kite GC, Nash RJ, Fellows LE. Phytochemistry. 1990;29:107–109.
    1. Kato A, Kano E, Adachi I, Molyneux RJ, Watson AA, Nash RJ, Fleet GWJ, Wormald MR, Kizu H, Ikeda K, Asano N. Tetrahedron: Asymmetry. 2003;14:325–331.
    2. Molyneux RJ, Benson M, Wong RY, Tropea JE, Elbein AD. J. Nat. Prod. 1988;51:1198–1206.
    1. Kinzy TG, Harger JW, Carr-Schmid A, Kwon J, Shastry M, Justice M, Dinman JD. Virology. 2002;300:60–70. - PubMed
    2. Achenbach TV, Slater PE, Brummerhop H, Bach T, Müller R. Antimicrob. Agents Chemother. 2000;44:2794–2801. - PMC - PubMed
    1. Powell RG, Weisleder D, Smith CR, Jr, Rohwedder WK. Tetrahedron Lett. 1970;11:815–818. - PubMed

Publication types